Quest Diagnostics

Quest Diagnostics. It is a leading American provider of diagnostic information services, offering a broad range of clinical laboratory tests and services. The company's data and insights are used by physicians, hospitals, health plans, and employers to inform medical decisions. Headquartered in Secaucus, New Jersey, its network of laboratories processes millions of tests annually, playing a critical role in the United States healthcare system.

History

The company's origins trace back to 1967 when pathologist Paul A. Brown founded a small medical laboratory in New York City. A major expansion occurred in 1982 when it was acquired by the pharmaceutical company Corning Incorporated, becoming Corning's laboratory services business. In 1996, this division was spun off as an independent, publicly traded company on the New York Stock Exchange under the symbol DGX. Significant growth was achieved through strategic acquisitions, including the 1999 purchase of SmithKline Beecham's clinical laboratories, which dramatically expanded its national footprint. Later, under the leadership of CEOs like Stephen H. Rusckowski and Jim Davis, it continued to expand its capabilities, acquiring companies such as Cleveland HeartLab and the clinical outreach business of Memorial Hermann Health System.

Services

The company provides a comprehensive menu of routine and esoteric diagnostic testing services. Its core offerings include blood tests, urinalysis, and tests for infectious diseases like COVID-19, HIV, and hepatitis. It also provides advanced genomic testing services through its subsidiary Quest Diagnostics Nichols Institute, specializing in areas such as oncology, cardiology, and neurology. Beyond traditional lab testing, it offers employer-based services like drug testing and occupational health screenings. The company provides health plans with services for risk adjustment and quality measure reporting, supporting programs like those from the Centers for Medicare & Medicaid Services.

Operations

The company operates one of the largest clinical laboratory networks in the United States, with major regional laboratories across the country and numerous patient service centers. It maintains a sophisticated logistics system for specimen transportation and utilizes advanced automation and information technology in its testing facilities. A key operational focus is its extensive IT infrastructure, which includes secure portals for physicians and patients, such as the MyQuest patient app, to access test results. Its operations are supported by partnerships with major health systems, biopharmaceutical companies for clinical trials, and retailers like Walmart for in-store collection sites.

Corporate affairs

The company is a constituent of the S&P 500 index and is led by CEO Jim Davis, with former CEO Stephen H. Rusckowski serving as Executive Chairman. Its corporate strategy emphasizes growth in advanced diagnostics, data analytics, and direct-to-consumer services. It engages in numerous public-private partnerships, including collaborations with the National Institutes of Health and the Department of Defense. The company's philanthropic arm, the Quest Diagnostics Foundation, focuses on community health and STEM education initiatives. It is regularly recognized on lists such as the Fortune 500 and the Dow Jones Sustainability Index.

Controversies

The company has faced several legal and regulatory challenges over the years. In 2009, it paid a $302 million settlement to the United States Department of Justice and the State of California over allegations it had improperly billed government health programs. In 2017, it agreed to a $6 million settlement with the U.S. Securities and Exchange Commission regarding violations of the Foreign Corrupt Practices Act in India. More recently, during the COVID-19 pandemic, it faced scrutiny and a warning letter from the U.S. Food and Drug Administration regarding accuracy concerns with a specific antibody test. The company has also been involved in litigation related to data breaches and patient notification practices.

Category:Companies listed on the New York Stock Exchange Category:Healthcare companies of the United States Category:Companies based in New Jersey